{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:27:19Z","timestamp":1790958439984,"version":"4.1.0"},"reference-count":30,"publisher":"SAGE Publications","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phcog Mag"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0973-1296.191441","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T02:32:17Z","timestamp":1475202737000},"page":"389","source":"Crossref","is-referenced-by-count":11,"title":["Human cytochrome P450 enzyme modulation by\n                    <i>Gymnema sylvestre<\/i>\n                    : A Predictive Safety evaluation by LC-MS\/MS"],"prefix":"10.1177","volume":"12","author":[{"given":"Karmakar","family":"Sanmoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bera","family":"Rammohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karmakar","family":"Samit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Das","family":"Chinmoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saha","family":"Arup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kundu","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkar","family":"Ratul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adhikari","family":"Dipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Tuhinadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"key-10.4103\/0973-1296.191441-1","first-page":"451","volume-title":"Pharmacokinetic interactions between herbal remedies and medicinal drugs","author":"Ioannides","year":"2002","journal-title":"Xenobiotica"},{"key":"key-10.4103\/0973-1296.191441-2","first-page":"163","volume-title":"Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals","author":"Brazier","year":"2003","journal-title":"Am J Ther"},{"key":"key-10.4103\/0973-1296.191441-3","first-page":"1","volume-title":"et al.The P450 superfamily: update on new sequences, gene mapping and recommended nomenclature","author":"Nebert","year":"1991","journal-title":"DNA Cell Biol"},{"key":"key-10.4103\/0973-1296.191441-4","first-page":"1155","volume-title":"Clinical importance of the cytochromes P450.The Lancet","author":"Nebert","year":"2002","journal-title":""},{"key":"key-10.4103\/0973-1296.191441-5","first-page":"561","volume-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","author":"Danielson","year":"2002","journal-title":"Curr Drug Metab"},{"key":"key-10.4103\/0973-1296.191441-6","first-page":"279","volume-title":"et al. Mechanism-based inhibition of cytochrome P4503A4 by therapeutic drugs","author":"Zhou","year":"2005","journal-title":"Clin Pharmacokinetics"},{"key":"key-10.4103\/0973-1296.191441-7","first-page":"328","volume-title":"A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24","author":"Gray","year":"1995","journal-title":"Genomics"},{"key":"key-10.4103\/0973-1296.191441-8","first-page":"285","volume-title":"Biochemistry and molecular biology of the human CYP2C subfamily","author":"Goldstein","year":"1994","journal-title":"Pharmacogenetics"},{"key":"key-10.4103\/0973-1296.191441-9","first-page":"349","volume-title":"Clinical relevance of genetic polymorphisms in the human CYP2C subfamily","author":"Goldstein","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0973-1296.191441-10","doi-asserted-by":"crossref","unstructured":"Totah RA, Rettie AE. Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics and clinical relevance. Clin. Pharmacol. Ther 2010; 77: 341-32.","DOI":"10.1016\/j.clpt.2004.12.267"},{"key":"key-10.4103\/0973-1296.191441-11","first-page":"438","volume-title":"Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases","author":"Jannetto","year":"2002","journal-title":"J Anal Toxicol"},{"key":"key-10.4103\/0973-1296.191441-12","first-page":"198","volume-title":"Metabolism of Xenobiotic compound and cytochrome P4501A2","author":"Otusaka","year":"2004","journal-title":"Foods Food Ingredients J Jpn"},{"key":"key-10.4103\/0973-1296.191441-13","first-page":"163","volume-title":"Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals","author":"Nicole","year":"2003","journal-title":"Am J Ther"},{"key":"key-10.4103\/0973-1296.191441-14","first-page":"349","volume-title":"St John\u2032s wort (Hypericum perforatum): drug interactions and clinical outcomes","author":"Henderson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0973-1296.191441-15","first-page":"112","volume-title":"Unwanted pregnancy on self medication with St.John\u2032s Wort despite hormonal contraception","author":"Schwarz","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0973-1296.191441-16","first-page":"1072","volume-title":"Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract","author":"Gaudineau","year":"2004","journal-title":"Biochem Biophys Res"},{"key":"key-10.4103\/0973-1296.191441-17","first-page":"273","volume-title":"An in-vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures","author":"Budzinski","year":"2000","journal-title":"Phytomedicine"},{"key":"key-10.4103\/0973-1296.191441-18","first-page":"208","volume-title":"Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Integr Cancer","author":"Shord","year":"2009","journal-title":"Ther"},{"key":"key-10.4103\/0973-1296.191441-19","first-page":"200","volume-title":"Interactions between herb and conventional medicines: the role of cytochrome P450 enzymes and P-glycoprotein","author":"Williamson","year":"2006","journal-title":"Pharmacologyonline"},{"key":"key-10.4103\/0973-1296.191441-20","doi-asserted-by":"crossref","unstructured":"Kerns EH, Di Li. Drug-like properties: concepts, structure, design and methods from ADME to toxicity optimization. Academic Press, Amsterdam, Boston. 2008.","DOI":"10.1016\/B978-012369520-8.50018-8"},{"key":"key-10.4103\/0973-1296.191441-21","unstructured":"WHO Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues. 2007."},{"key":"key-10.4103\/0973-1296.191441-22","first-page":"336","volume-title":"The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions","author":"Obach","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0973-1296.191441-23","first-page":"1005","volume-title":"In vitro drug interactions of cytochrome P450: An evaluation of fluorogenic to conventional substrates","author":"Lawrence","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"key-10.4103\/0973-1296.191441-24","unstructured":"Tiwari P, Mishra BN, Sangwan SN. Phytochemical and Pharmacological Properties of Gymnema sylvestre: An Important Medicinal Plant. Bio Med Res Int. Article ID. 2014; 830285: 1-32."},{"key":"key-10.4103\/0973-1296.191441-25","first-page":"67","volume-title":"Modulation of cytochrome P450 enzyme system by selected flavonoids","author":"Hodek","year":"2009","journal-title":"Neuroendocrinol Lett"},{"key":"key-10.4103\/0973-1296.191441-26","first-page":"429","volume-title":"Inhibitory effects of polyphenols on human cytochrome P4503A4 and 2C9 activity","author":"Kimura","year":"2010","journal-title":"Food Chem Toxicol"},{"key":"key-10.4103\/0973-1296.191441-27","first-page":"1955","volume-title":"Human cytochromes P450 associated with the Phase-1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families","author":"Lewis","year":"2003","journal-title":"Curr Med Chem"},{"key":"key-10.4103\/0973-1296.191441-28","first-page":"89","volume-title":"Quantitative structure-activity relationships (QSARs) within human cytochromes P450 substrates of the CYP2 family","author":"Lewis","year":"2004","journal-title":"Toxicol in vitro"},{"key":"key-10.4103\/0973-1296.191441-29","first-page":"374","volume-title":"The challenges of dealing with promiscuous drug-metabolizing enzymes, receptors and transporters","author":"Ma","year":"2008","journal-title":"Curr Drug Metab"},{"key":"key-10.4103\/0973-1296.191441-30","first-page":"49","volume-title":"Standardization of some herbal antidiabetic drugs in polyherbal formulation","author":"Chandel","year":"2011","journal-title":"Phcog Res","ISSN":"https:\/\/id.crossref.org\/issn\/0974-8490","issn-type":"print"}],"container-title":["Pharmacognosy Magazine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:42:57Z","timestamp":1718617377000},"score":1,"resource":{"primary":{"URL":"https:\/\/phcog.com\/article\/view\/2016\/12\/47s\/s389-s394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":30,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016]]}},"alternative-id":["191441"],"URL":"https:\/\/doi.org\/10.4103\/0973-1296.191441","relation":{},"ISSN":["0973-1296"],"issn-type":[{"value":"0973-1296","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}